An interventional study of CAUD-PIN (CAUchemar Detection on INdividualized Parameters) - AI-based predictive algorithm forTrauma-related nightmare awakenings in PTSD - Post Traumatic Stress Disorder and Trauma-related Nightmares, sponsored by Direction Centrale du Service de Santé des Armées. Recruiting at 3 sites in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-01.
Sponsored by Direction Centrale du Service de Santé des Armées · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Combat Disorders with a site in France — 7 open to participants now, 7 under way, 2 of them phase 3. Combat Disorders · France.
Among the 13 studies in Combat Disorders with a site in France, this one is the 9th largest by planned enrollment of the 10 interventional ones that give a count, is one of 5 that started in 2026, is one of 7 with no phase, and was the 7th registered.
204 studies on the registry are indexed under Combat Disorders; 93 are open to participants now.
Browse Combat Disorders studies →7 of the 13 studies in Combat Disorders with a site in France are open now. Recruiting first, the newest first:
University Hospital, Strasbourg, France · Sites in France
Ages 12–18
Almaviva Sante · Sites in France
Ages 18+
University Hospital, Tours · Sites in France
Ages 18–65
University Hospital, Toulouse · Sites in France
Ages 18–75 · Women only
Hospices Civils de Lyon · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 53 Combat Disorders studies recruiting now, 22 (42%) set no upper age limit and 26 (49%) stop at 75 or younger; 10 take children under 18; 5 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 27 is below the median of 72 across 171 interventional studies indexed under Combat Disorders.
Median enrollment 70 across the 10 interventional studies, 200 across the 3 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 10 most frequent:
Direction Centrale du Service de Santé des Armées is the lead sponsor of 95 studies on the registry; 33 are open to participants now.
Direction Centrale du Service de Santé des Armées has 1 study filed under Combat Disorders — fewer than ten, so there is no comparison to draw.
3 of the studies in Combat Disorders with a site in France that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07927192Phase 3University Hospital, ToursMedical Nitrous Oxide Combined With Personalized Traumatic Script Exposure for the Treatment of Post-Traumatic Stress Disorder | 2027-09 |
| NCT07794332University Hospital, Strasbourg, FranceSymptom Assessment in Adolescents Placed on Child Welfare | 2027-09-01 |
| NCT07851480Direction Centrale du Service de Santé des ArméesValidation of an Algorithm for Predicting Awakenings Associated With Trauma-related Nightmares, Based on the Analysis of Physiological Patterns in Military and Former Military Patients Suffering From Post-traumatic Stress Disorder | 2027-10 |
Add all 3 to your calendar (.ics) → With an account.
Among the 13 studies in Combat Disorders with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to validate an artificial intelligence algorithm called CAUD-PIN (CAUchemar Detection on INdividualized Parameters) to predict nightmare-related awakenings in military personnel and veterans suffering from post-traumatic stress disorder (PTSD). The main question it aim to answer is :
Participants will:
Wear two non-invasive devices at home - an EEG headband and a wrist-worn sensor bracelet - for 15 consecutive nights Press a button on the bracelet each time they wake up from a nightmare Complete sleep and daytime diaries every evening and morning Attend two clinical assessments (at enrollment and at the end of the study, one month later) at one of the three participating military hospitals
The algorithm will be applied to the recorded data after collection and does not intervene in real time or affect participants' standard medical care in any way.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
French Military personnel and/or veterans with PTSD wear two non-invasive wearable devices at home - an EEG headband (Hypnodyne Zmax Lite) and a multisensor bracelet (Empatica EmbracePlus) - for 15 consecutive nights. Participants press a button on the bracelet to report each nightmare-related awakening. Physiological data are analyzed post-hoc by the CAUD-PIN algorithm to validate its ability to predict trauma-related nightmare awakenings. Two clinical assessments are conducted at enrollment and at study completion.
Diagnostic Test: CAUD-PIN (CAUchemar Detection on INdividualized Parameters) - AI-based predictive algorithm forTrauma-related nightmare awakenings
CAUD-PIN (CAUchemar Detection on INdividualized Parameters) is a non-invasive, AI-based predictive algorithm developed by the VIFASOM research team (UMR 7330, Université Paris Cité / French Military Health Service) from the SOMMEPT clinical project. It analyzes multimodal physiological signals recorded during home sleep to identify patterns preceding Trauma-related nightmare awakenings in military patients with PTSD. Data are collected using two wearable devices: an EEG headband (Hypnodyne Zmax Lite) measuring brain activity and sleep stages, and a wrist-worn multisensor bracelet (Empatica EmbracePlus) measuring heart rate, electrodermal activity, skin temperature, and motor activity. The algorithm is applied exclusively post-hoc to pseudonymized recordings, with no real-time intervention and no impact on participants' standard medical care.
Sensitivity of the CAUD-PIN algorithm in predicting Trauma-related nightmare awakenings
Sensitivity will be calculated as the number of Trauma-related nightmare awakenings correctly identified by the CAUD-PIN algorithm divided by the total number of confirmed trauma-related nightmare awakenings, multiplied by 100. Unit of Measure: Percentage
Time frame: During the 15 consecutive nights of home sleep recording
Specificity of the CAUD-PIN algorithm for predicting Trauma-related nightmare awakenings
Specificity will be calculated as the number of events correctly classified as not being trauma-related nightmare awakenings divided by the total number of confirmed non-nightmare events, multiplied by 100. Unit of Measure: Percentage
Time frame: During the 15 consecutive nights of home sleep recording
Positive predictive value of the CAUD-PIN algorithm
Positive predictive value will be calculated as the number of correctly predicted trauma-related nightmare awakenings divided by the total number of trauma-related nightmare awakenings predicted by the CAUD-PIN algorithm, multiplied by 100. Unit of Measure: Percentage
Time frame: During the 15 consecutive nights of home sleep recording
Negative predictive value of the CAUD-PIN algorithm
Negative predictive value will be calculated as the number of events correctly predicted as not being trauma-related nightmare awakenings divided by the total number of events predicted as not being trauma-related nightmare awakenings, multiplied by 100. Unit of Measure: Percentage
Time frame: During the 15 consecutive nights of home sleep recording
Prediction lead time before trauma-related nightmare awakening
Mean time (in seconds) between the physiological predictive pattern detected by the CAUD-PIN algorithm and the participant's button press indicating a trauma-related nightmare awakening. Unit of Measure: Seconds
Time frame: Through 15 nights of recording
Intra- and inter-individual variability in heart rate preceding trauma-related nightmare awakenings
Intra- and inter-individual variability in heart rate (beats per minute, bpm) preceding trauma-related nightmare awakenings. Variability will be quantified using: * Within-subject standard deviation (SD) * Between-subject variance estimated using mixed-effects models
Time frame: During the 15 consecutive nights of home sleep recording
Intra- and inter-individual variability in electrodermal activity preceding trauma-related nightmare awakenings
Intra- and inter-individual variability in electrodermal activity (microsiemens, µS) preceding trauma-related nightmare awakenings. Variability will be quantified using: * Within-subject standard deviation (SD) * Between-subject variance estimated using mixed-effects models
Time frame: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)
Intra- and inter-individual variability in skin temperature preceding trauma-related nightmare awakenings
Intra- and inter-individual variability in skin temperature (°C) preceding trauma-related nightmare awakenings. Variability will be quantified using: * Within-subject standard deviation (SD) * Between-subject variance estimated using mixed-effects models
Time frame: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)
Intra- and inter-individual variability in motor activity preceding trauma-related nightmare awakenings
Intra- and inter-individual variability in motor activity (activity counts) preceding trauma-related nightmare awakenings. Variability will be quantified using: * Within-subject standard deviation (SD) * Between-subject variance estimated using mixed-effects models
Time frame: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)
Area Under the Curve (AUC) of the CAUD-PIN algorithm on combined dataset
Area Under the Receiver Operating Characteristic Curve (AUC, unitless) of the CAUD-PIN algorithm when trained and evaluated on the CAUD-PIN dataset alone compared to the combined dataset (SOMMEPT + CAUD-PIN).
Time frame: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)
F1-score of the CAUD-PIN algorithm on combined dataset
F1-score (unitless) of the CAUD-PIN algorithm when trained and evaluated on the CAUD-PIN dataset alone compared to the combined dataset (SOMMEPT + CAUD-PIN).
Time frame: After completion of all participant data collection, following the 15-night recording period for each participant (approximately 18 months after study start)
Correlation between PCL-5 total score and percentage of trauma-related nightmare nights
PTSD severity will be assessed at T1 using the PTSD Checklist for DSM-5 (PCL-5) total score, ranging from 0 to 80 points. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Beck Depression Inventory total score and percentage of trauma-related nightmare nights
Depression severity will be assessed at T1 using the Beck Depression Inventory (BDI) total score, ranging from 0 to 63 points. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between WHOQOL-BREF score and percentage of trauma-related nightmare nights
Quality of life will be assessed at T1 using the World Health Organization Quality of Life-BREF (WHOQOL-BREF) \[specify total or domain score and range\]. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Nightmare Severity Index score and percentage of trauma-related nightmare nights
Nightmare severity will be assessed at T1 using the Nightmare Severity Index (NSI) total score. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between mean number of trauma-related nightmare awakenings per night and percentage of trauma-related nightmare nights
The mean number of trauma-related nightmare awakenings per night will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights. The percentage of trauma-related nightmare nights will be calculated as the percentage of valid recording nights containing at least one confirmed awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: During the 15 consecutive nights of home sleep recording
Correlation between mean heart rate and percentage of trauma-related nightmare nights
Heart rate will be measured in beats per minute using Empatica EmbracePLUS. For each participant, mean heart rate will be calculated across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: During the 15 consecutive nights of home sleep recording
Correlation between mean electrodermal activity and percentage of trauma-related nightmare nights
Electrodermal activity will be measured in microsiemens (µS) using Empatica EmbracePLUS. For each participant, mean electrodermal activity will be calculated across across sleep period preceeding trauma-ralated awakeking across across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: During the 15 consecutive nights of home sleep recording
Correlation between mean skin temperature and percentage of trauma-related nightmare nights
Skin temperature will be measured in degrees Celsius using Empatica EmbracePLUS. For each participant, mean skin temperature will be calculated across across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: During the 15 consecutive nights of home sleep recording
Correlation between mean motor activity and percentage of trauma-related nightmare nights
Motor activity will be measured in activity counts using Empatica EmbracePLUS. For each participant, mean motor activity will be calculated across across sleep period preceeding trauma-ralated awakeking across 15 nights. Trauma-related nightmare frequency will be calculated as the percentage of valid recording nights containing at least one participant-confirmed trauma-related nightmare awakening. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: During the 15 consecutive nights of home sleep recording
Correlation between trauma-related nightmare awakening frequency and change in PCL-5 total score between T1 and T2
Trauma-related nightmare frequency will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights, expressed as awakenings per night. PTSD severity will be assessed at T1 and T2 using the PCL-5 total score, ranging from 0 to 80 points. Change will be calculated as the difference between the PCL-5 total scores obtained at T1 and T2. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)
Correlation between trauma-related nightmare awakening frequency and change in Beck Depression Inventory total score between T1 and T2
Trauma-related nightmare frequency will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights, expressed as awakenings per night. Depression severity will be assessed at T1 and T2 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Change will be calculated as the difference between the BDI total scores obtained at T1 and T2. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)
Correlation between trauma-related nightmare awakening frequency and change in WHOQOL-BREF score between T1 and T2
Trauma-related nightmare frequency will be calculated as the total number of participant-confirmed trauma-related nightmare awakenings divided by the number of valid recording nights, expressed as awakenings per night. Quality of life will be assessed at T1 and T2 using the WHOQOL-BREF \[specify total or domain score and range\]. Change will be calculated as the difference between the WHOQOL-BREF scores obtained at T1 and T2. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: From Visit 1 (baseline) to Visit 2 (end of study, Day 30 ± 5 days after inclusion)
Correlation between PCL-5 total score at T1 and PSQI total score
PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Subjective sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI) total score, ranging from 0 to 21 points, with higher scores indicating poorer sleep quality. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between PCL-5 total score at T1 and mean total sleep time
PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Total sleep time will be measured in minutes usingHypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between PCL-5 total score at T1 and mean sleep efficiency
PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Sleep efficiency will be measured usingHypnodyne Zmax Lite device and PSQI questionnary, calculated as total sleep time divided by time in bed and multiplied by 100, and averaged across valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between PCL-5 total score at T1 and mean wake after sleep onset
PTSD severity will be assessed at T1 using the PCL-5 total score, ranging from 0 to 80 points. Wake after sleep onset will be measured in minutes using Hypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Beck Depression Inventory total score at T1 and PSQI total score
Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Subjective sleep quality will be assessed using the PSQI total score, ranging from 0 to 21 points, with higher scores indicating poorer sleep quality. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Beck Depression Inventory total score at T1 and mean total sleep time
Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Total sleep time will be measured in minutes using Hypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Beck Depression Inventory total score at T1 and mean sleep efficiency
Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Sleep efficiency will be measured using Hypnodyne Zmax Lite device and PSQI questionnary, calculated as total sleep time divided by time in bed and multiplied by 100, and averaged across valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Beck Depression Inventory total score at T1 and mean wake after sleep onset
Depression severity will be assessed at T1 using the Beck Depression Inventory total score, ranging from 0 to 63 points. Wake after sleep onset will be measured in minutes using using Hypnodyne Zmax Lite device and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Nightmare Severity Index score at T1 and PSQI total score
Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Subjective sleep quality will be assessed using the PSQI total score, ranging from 0 to 21 points, with higher scores indicating poorer sleep quality. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Nightmare Severity Index score at T1 and mean total sleep time
Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Total sleep time will be measured in minutes using Hypnodyne Zmax Lite and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Nightmare Severity Index score at T1 and mean sleep efficiency
Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Sleep efficiency will be measured using Hypnodyne Zmax Lite and PSQI questionnary, calculated as total sleep time divided by time in bed and multiplied by 100, and averaged across valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Correlation between Nightmare Severity Index score at T1 and mean wake after sleep onset
Nightmare severity will be assessed at T1 using the Nightmare Severity Index total score.. Wake after sleep onset will be measured in minutes using Hypnodyne Zmax Lite and PSQI questionnary and averaged across all valid recording nights. A single Pearson or Spearman correlation coefficient will be reported. Unit of Measure: Correlation coefficient (r).
Time frame: At Visit 1 (baseline) and during the 15 consecutive nights of home sleep recording
Plan to share: No — Individual participant data will not be shared. This study involves military personnel and veterans with PTSD, whose physiological and psychological data are considered highly sensitive. Data are pseudonymized and managed in accordance with the French General Data Protection Regulation (GDPR, EU 2016/679) and the Reference Methodology MR-001. Access is restricted to authorized members of the research team. Only aggregated and de-identified results will be disseminated through scientific publications and conference presentations.
Started Apr 2026 (actual). Primary completion is estimated for Oct 2027, 18 months after the start.
Of 76 non-industry interventional studies with no phase under Combat Disorders, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 44. This study's planned 18 months is below that.
Counting every sponsor, half of 82 studies reached it within 25 months; a quarter within 12 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Direction Centrale du Service de Santé des Armées